BioEnterprise, based in Cleveland, Ohio, is an organization that assists early stage biotech and medical device firms. Since 2002 it has created 80 new companies, attracted more than $860 million of new funding to these companies, and concluded over 300 tech transfer deals. AS a result of this activity Cleveland has become the US’s “new healthcare innovation destination”.

 

Tom Facklam is a former VP of Life Sciences at the Alberta Research Council, and CEO of IFASA [Institute for Food and Agricultural Science of Alberta]. He has spent several years at BioEnterprise before returning to Alberta recently. Tom will describe the BioEnterprise approach.